Copyright: ©Author(s) 2026.
World J Gastrointest Oncol. Sep 15, 2026; 18(9): 120566
Published online Sep 15, 2026. doi: 10.4251/wjgo.120566
Published online Sep 15, 2026. doi: 10.4251/wjgo.120566
Table 2 Comparative outcomes of treatment modalities for early esophageal cancer
| Outcome | EMR | ESD | Esophagectomy |
| En bloc resection rate | Low–moderate (piecemeal common for larger lesions) | High (> 90%-95%) | Not applicable |
| R0 resection rate | Moderate (lower for large lesions) | High (approximately 85%-95%) | High |
| Local recurrence rate | Higher (up to 10%-20%) | Low (< 1%-5%) | Very low |
| 5-year overall survival | Approximately 85%-98% (selected patients) | Approximately 90%-99% (selected patients) | Approximately 85%-95% |
| Procedure-related mortality | Very low (< 0.5%) | Very low (< 0.5%) | Higher (2%-9%) |
| Major adverse events | Bleeding, stricture | Perforation, stricture | Pulmonary complications, anastomotic leak |
- Citation: Peng QY, Huang XP. Endoscopic and surgical management of early esophageal cancer: Current evidence and evolving oncologic strategies. World J Gastrointest Oncol 2026; 18(9): 120566
- URL: https://www.wjgnet.com/1948-5204/full/v18/i9/120566.htm
- DOI: https://dx.doi.org/10.4251/wjgo.120566